These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27613844)

  • 1. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
    Wu N; Jia D; Ibrahim AH; Bachurski CJ; Gronostajski RM; MacPherson D
    Oncotarget; 2016 Sep; 7(36):57514-57524. PubMed ID: 27613844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.
    Semenova EA; Kwon MC; Monkhorst K; Song JY; Bhaskaran R; Krijgsman O; Kuilman T; Peters D; Buikhuisen WA; Smit EF; Pritchard C; Cozijnsen M; van der Vliet J; Zevenhoven J; Lambooij JP; Proost N; van Montfort E; Velds A; Huijbers IJ; Berns A
    Cell Rep; 2016 Jul; 16(3):631-43. PubMed ID: 27373156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Cell Lung Cancer Plasticity Enables NFIB-Independent Metastasis.
    Ko JH; Lambert KE; Bhattacharya D; Lee MC; Colón CI; Hauser H; Sage J
    Cancer Res; 2024 Jan; 84(2):226-240. PubMed ID: 37963187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor I/B is an oncogene in small cell lung cancer.
    Dooley AL; Winslow MM; Chiang DY; Banerji S; Stransky N; Dayton TL; Snyder EL; Senna S; Whittaker CA; Bronson RT; Crowley D; Barretina J; Garraway L; Meyerson M; Jacks T
    Genes Dev; 2011 Jul; 25(14):1470-5. PubMed ID: 21764851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.
    Denny SK; Yang D; Chuang CH; Brady JJ; Lim JS; Grüner BM; Chiou SH; Schep AN; Baral J; Hamard C; Antoine M; Wislez M; Kong CS; Connolly AJ; Park KS; Sage J; Greenleaf WJ; Winslow MM
    Cell; 2016 Jul; 166(2):328-342. PubMed ID: 27374332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
    Horie M; Miyashita N; Mattsson JSM; Mikami Y; Sandelin M; Brunnström H; Micke P; Nagase T; Saito A
    J Pathol; 2018 Oct; 246(2):154-165. PubMed ID: 29876935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
    Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
    J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB.
    Zhang Q; Cao LY; Cheng SJ; Zhang AM; Jin XS; Li Y
    Oncol Rep; 2015 Mar; 33(3):1335-41. PubMed ID: 25591821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice.
    Ferone G; Song JY; Krijgsman O; van der Vliet J; Cozijnsen M; Semenova EA; Adams DJ; Peeper D; Berns A
    Cell Rep; 2020 Mar; 30(11):3837-3850.e3. PubMed ID: 32187553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A crucial requirement for Hedgehog signaling in small cell lung cancer.
    Park KS; Martelotto LG; Peifer M; Sos ML; Karnezis AN; Mahjoub MR; Bernard K; Conklin JF; Szczepny A; Yuan J; Guo R; Ospina B; Falzon J; Bennett S; Brown TJ; Markovic A; Devereux WL; Ocasio CA; Chen JK; Stearns T; Thomas RK; Dorsch M; Buonamici S; Watkins DN; Peacock CD; Sage J
    Nat Med; 2011 Oct; 17(11):1504-8. PubMed ID: 21983857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.
    Schaffer BE; Park KS; Yiu G; Conklin JF; Lin C; Burkhart DL; Karnezis AN; Sweet-Cordero EA; Sage J
    Cancer Res; 2010 May; 70(10):3877-83. PubMed ID: 20406986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer.
    Gao G; Hausmann S; Flores NM; Benitez AM; Shen J; Yang X; Person MD; Gayatri S; Cheng D; Lu Y; Liu B; Mazur PK; Bedford MT
    Nat Commun; 2023 Jan; 14(1):363. PubMed ID: 36690626
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Jia D; Augert A; Kim DW; Eastwood E; Wu N; Ibrahim AH; Kim KB; Dunn CT; Pillai SPS; Gazdar AF; Bolouri H; Park KS; MacPherson D
    Cancer Discov; 2018 Nov; 8(11):1422-1437. PubMed ID: 30181244
    [No Abstract]   [Full Text] [Related]  

  • 14. Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.
    Chen J; Guanizo A; Luong Q; Jayasekara WSN; Jayasinghe D; Inampudi C; Szczepny A; Garama DJ; Russell PA; Ganju V; Cain JE; Watkins DN; Gough DJ
    Oncogene; 2022 Jan; 41(1):138-145. PubMed ID: 34675406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of nuclear factor I transcription/replication factor in the early stage of chondrocytic differentiation.
    Uchihashi T; Kimata M; Tachikawa K; Koshimizu T; Okada T; Ihara-Watanabe M; Sakai N; Kogo M; Ozono K; Michigami T
    Bone; 2007 Dec; 41(6):1025-35. PubMed ID: 17904922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
    Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive genomic profiles of small cell lung cancer.
    George J; Lim JS; Jang SJ; Cun Y; Ozretić L; Kong G; Leenders F; Lu X; Fernández-Cuesta L; Bosco G; Müller C; Dahmen I; Jahchan NS; Park KS; Yang D; Karnezis AN; Vaka D; Torres A; Wang MS; Korbel JO; Menon R; Chun SM; Kim D; Wilkerson M; Hayes N; Engelmann D; Pützer B; Bos M; Michels S; Vlasic I; Seidel D; Pinther B; Schaub P; Becker C; Altmüller J; Yokota J; Kohno T; Iwakawa R; Tsuta K; Noguchi M; Muley T; Hoffmann H; Schnabel PA; Petersen I; Chen Y; Soltermann A; Tischler V; Choi CM; Kim YH; Massion PP; Zou Y; Jovanovic D; Kontic M; Wright GM; Russell PA; Solomon B; Koch I; Lindner M; Muscarella LA; la Torre A; Field JK; Jakopovic M; Knezevic J; Castaños-Vélez E; Roz L; Pastorino U; Brustugun OT; Lund-Iversen M; Thunnissen E; Köhler J; Schuler M; Botling J; Sandelin M; Sanchez-Cespedes M; Salvesen HB; Achter V; Lang U; Bogus M; Schneider PM; Zander T; Ansén S; Hallek M; Wolf J; Vingron M; Yatabe Y; Travis WD; Nürnberg P; Reinhardt C; Perner S; Heukamp L; Büttner R; Haas SA; Brambilla E; Peifer M; Sage J; Thomas RK
    Nature; 2015 Aug; 524(7563):47-53. PubMed ID: 26168399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer.
    Coe BP; Thu KL; Aviel-Ronen S; Vucic EA; Gazdar AF; Lam S; Tsao MS; Lam WL
    PLoS One; 2013; 8(8):e71670. PubMed ID: 23967231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing amplicon-based next generation sequencing in the diagnosis of small cell lung carcinoma metastases.
    Meder L; König K; Fassunke J; Ozretić L; Wolf J; Merkelbach-Bruse S; Heukamp LC; Buettner R
    Exp Mol Pathol; 2015 Dec; 99(3):682-6. PubMed ID: 26546837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer.
    Becker-Santos DD; Lonergan KM; Gronostajski RM; Lam WL
    EBioMedicine; 2017 Aug; 22():2-9. PubMed ID: 28596133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.